toripalimab
junshi biosciences,coherus
['breast', 'toripalimab', 'lung', 'coherus']
today, we re presenting two abstracts annual meeting highlighting trials evaluating #toripalimab as a combination treatment for patients with resectable stage ii/iii non-small cell lung cancer and with metastatic or recurrent triple-negative breast cancer. #asco23 
Leader in developing and commercializing high-quality, high-value biosimilar therapeutics.